New combo therapy shows promise for tough stomach cancer
NCT ID NCT04053205
First seen May 23, 2026 · Last updated Jun 12, 2026 · Updated 5 times
Summary
This study tested a new drug called gentuximab combined with the chemotherapy paclitaxel in 76 people with advanced stomach or gastroesophageal junction cancer that had worsened after initial treatment. The goal was to find safe doses and see if the combination could shrink tumors or slow cancer growth. The study is now complete.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED GASTRIC OR GASTROESOPHAGEAL JUNCTION CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Fujian Tumor Hospital
Fuzhou, Fujian, China
-
Jiangsu Province Hospital
Nanjing, Jiangsu, China
-
Shanghai East Hospital
Shanghai, China
-
Shanghai First People's Hospital
Shanghai, China
-
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
-
The Affiliated Tumor Hospital of Harbin Medical University
Harbin, Heilongjiang, China
-
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
-
The First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
-
The First Hospital of Jilin University
Changchun, Jilin, China
-
The Sixth Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China
-
Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology
Hangzhou, Zhejiang, China
-
Union Hospital of Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.